© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
September 29, 2021
An expert explains the science of vaccine- and infection-induced immunity, and how it informs the timeline of COVID-19 outbreaks this year.
A team from a tertiary center in the Middle East used a multidisciplinary approach to increase immunization.
September 21, 2021
With the Delta cases surging in recent weeks, and the upcoming flu season almost upon us, here is a glimpse of what providers and the public can expect when both viruses are circulating.
September 16, 2021
The emergency authorization granted to combination bamlanivimab and etesevimab is the second indicated in this last year.
September 14, 2021
Here are some insights into this upcoming 2021-2022 influenza season as well as concerns of the twindemic and addressing both the seasonal and pandemic viruses simultaneously.
September 09, 2021
The shot will be its NanoFlu/NVX-CoV2373 vaccine using the company’s Matrix-M adjuvant platform.
September 08, 2021
Past research has observed links between cardiovascular disease and influenza infection. Vaccination may benefit at-risk patients.
September 07, 2021
The first participants were vaccinated in the study with Pfizer’s respiratory syncytial virus (RSV) investigational vaccine candidate in adults ages 60 or older.
August 30, 2021
Persons living with HIV are susceptible to TB and also appear at increased risk for infecting strains acquiring rifampicin-resistance.
August 26, 2021
An Israel study estimates vaccinated persons' risk of side effects including myocarditis, relative to the risk brought on by SARS-CoV-2 infection.